RankAlpha logo
Back to Rankings

MNDR

Mobile-health Network SolutionsF
Nasdaq / Health Care Equipment & Services
Last Price
$0.95-$0.00 (-0.26%)
At close · 2026-11-19
View Chart
Documents
3
Stored
Transcripts
0
Recent loaded
Latest document
2026-10-30
Related article

Document history

Transcripts and related coverage stored for MNDR. Related articles may discuss other companies and are not verified issuer releases.

3 shown
Related articleQuarter not tagged2026-10-30

Mobile-health Network Solutions Reports FY2026 Results, Highlights Investments in AI, Advances Ghana Expansion, and Launches MaNaDr Health Operating Ecosystem for Global Rollout

TMX Newsfile
Singapore, Singapore--(Newsfile Corp. - October 30, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health ecosystem headquartered in Singapore, today announced its financial and operating results for the fiscal year ended June 30, 2026, highlighting the positive impact of its strategic investments in artificial intelligence, its expansion into Africa, and the continued development of new technology partnerships expected to support future growth. FY2026 Financial Highlights For FY2026, the Company reported revenue of approximately US$7.74 million an increase of 1.2% year-over-year, reflecting resilience in its telemedicine segment which grew by 3.9% that was partially offset by a decline in the sale of medicines and medical device segment. Gross profit increased by 28.3% year-over-year to US$1.64 million as gross margins expanded to 21.2% vs 16.7% the prior year. The year over year improvements in gross profit and gross margins reflect a continued shift towards higher-margin services and operational efficiencies. The net loss narrowed to US$3.19 million, an improvement of 9.7%, compared to the prior year driven by the significant gross profit increase while the operating expenses increased only 2.3% as the company continued investing in technology, product innovation, and geographic expansion. AI Investments Delivering Operational Benefits Dr. Siaw Tung Yeng, Co-Chief Executive Officer and Chairman of MNDR, said: "Over the past year, we have invested significantly in artificial intelligence across our healthcare ecosystem. We are now seeing the benefits of these investments through improved operational efficiency, enhanced patient engagement, stronger platform capabilities, and a growing range of AI-enabled healthcare solutions. Our AI strategy is not only improving healthcare delivery but also strengthening the foundation for sustainable long-term growth." The Company continued expanding its AI capabilities by deploying proprietary healthcare AI technologies, including AI-powered patient engagement and clinical support solutions integrated into the MaNaDr Health Operating System. Ghana Expansion Progressing MNDR has advanced its planned entry into Africa through its collaboration with the Jospong Group of Companies, one of Ghana's leading diversified business groups. The initiative will deploy M…Read full document

Singapore, Singapore--(Newsfile Corp. - October 30, 2026) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI-powered digital health ecosystem headquartered in Singapore, today announced its financial and operating results for the fiscal year ended June 30, 2026, highlighting the positive impact of its strategic investments in artificial intelligence, its expansion into Africa, and the continued development of new technology partnerships expected to support future growth. FY2026 Financial Highlights For FY2026, the Company reported revenue of approximately US$7.74 million an increase of 1.2% year-over-year, reflecting resilience in its telemedicine segment which grew by 3.9% that was partially offset by a decline in the sale of medicines and medical device segment. Gross profit increased by 28.3% year-over-year to US$1.64 million as gross margins expanded to 21.2% vs 16.7% the prior year. The year over year improvements in gross profit and gross margins reflect a continued shift towards higher-margin services and operational efficiencies. The net loss narrowed to US$3.19 million, an improvement of 9.7%, compared to the prior year driven by the significant gross profit increase while the operating expenses increased only 2.3% as the company continued investing in technology, product innovation, and geographic expansion. AI Investments Delivering Operational Benefits Dr. Siaw Tung Yeng, Co-Chief Executive Officer and Chairman of MNDR, said: "Over the past year, we have invested significantly in artificial intelligence across our healthcare ecosystem. We are now seeing the benefits of these investments through improved operational efficiency, enhanced patient engagement, stronger platform capabilities, and a growing range of AI-enabled healthcare solutions. Our AI strategy is not only improving healthcare delivery but also strengthening the foundation for sustainable long-term growth." The Company continued expanding its AI capabilities by deploying proprietary healthcare AI technologies, including AI-powered patient engagement and clinical support solutions integrated into the MaNaDr Health Operating System. Ghana Expansion Progressing MNDR has advanced its planned entry into Africa through its collaboration with the Jospong Group of Companies, one of Ghana's leading diversified business groups. The initiative will deploy MNDR's AI-powered digital healthcare platform in Ghana and establish a foundation for future expansion across the African continent. The Company is undertaking the operational setup and preparatory activities required for market entry and expects to progressively roll out services after completing implementation activities and meeting local regulatory requirements. The initiative aims to improve healthcare accessibility and broaden adoption of digital healthcare services in Ghana. Dr. Siaw Tung Yeng added: "Ghana represents an important strategic milestone in our international expansion journey. Through our partnership with the Jospong Group, we are laying the groundwork to introduce AI-powered healthcare solutions to a large and underserved market while creating a scalable platform for future growth across Africa." MaNaDr Health Operating Ecosystem Positioned for Future Growth The Company also highlighted the upcoming commercial rollout of the MaNaDr Health Operating Ecosystem, an integrated healthcare platform that connects virtual care, clinic management, electronic medical records, artificial intelligence technologies, patient engagement solutions, pharmacy services, and healthcare logistics into a single operating environment. The ecosystem is scheduled to launch initially in Singapore on November 2, 2026, followed by a phased international rollout. Developed over more than two and a half years, the ecosystem combines MaNaDr's patient-facing healthcare platform with advanced clinic management and electronic medical record capabilities, enabling healthcare providers to seamlessly manage both virtual and in-person consultations while maintaining continuity of patient information throughout the patient journey. The platform incorporates MNDR's proprietary artificial intelligence technologies, including Phi GPT for AI-assisted clinical documentation and Aiko, an AI healthcare companion designed to provide patient guidance, reminders, and ongoing support between consultations. Additional services such as pharmacy fulfillment, healthcare logistics, remote diagnostics, community engagement capabilities, and curated healthcare marketplace services further strengthen the platform's value proposition. Management believes the MaNaDr Health Operating Ecosystem will become a key driver of future growth by providing a scalable technology foundation that enhances healthcare accessibility, improves patient engagement, supports healthcare providers, and facilitates the Company's expansion into new markets. Outlook Dr. Siaw Tung Yeng concluded: "As we look ahead, we remain focused on executing our AI-first growth strategy, expanding into new markets, and strengthening our ecosystem through strategic partnerships. We believe the continued advancement of our AI platform, the Ghana initiative, and the global rollout of the MaNaDr Health Operating Ecosystem will create meaningful opportunities for growth and value creation in the years ahead." About Mobile-health Network Solutions Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The Company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human through technology. For more information, please visit the Company's website. Forward-Looking Statements Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the Company's financial performance and business prospects, anticipated benefits of the Company's AI investments, Ghana expansion, and MaNaDr Health Operating Ecosystem, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law. For inquiries, please contact: Mobile-health Network Solutions Investor Relations Contact: 2 Venture Drive, #07-08 Vision Exchange Singapore 608526 Office: +65 6222 5223 Email: [email protected] Investor Relations Inquiries: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, New York 10036 Office: (646) 893-5835 Email: [email protected] To view the source version of this press release, please visit https://www.newsfilecorp.com/release/321777

Related articleQuarter not tagged2025-11-01

Mobile-health Network Solutions Reports FY2025 Results and Operational Update

Newsfile
Singapore, Singapore--(Newsfile Corp. - October 31, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced its financial results for the fiscal year ended June 30, 2025 ("FY2025"), and outlined its strategy to scale its proprietary AI-driven virtual-care platform across high-growth emerging markets. During FY2025, the Company completed its transition from an asset-heavy structure to an asset-light virtual-care platform, significantly reducing operational costs and positioning MNDR for sustainable, scalable growth. Management Commentary and Strategic Outlook – Efficiency for Public Good "FY2025 marked a defining year as MNDR completed its transformation into an AI-powered, asset-light health platform," said Dr. Siaw Tung Yeng, Co-CEO of MNDR. "In an era where healthcare systems face rising costs and stretched resources, our mission is to stay lean, stay intelligent, and stay aligned with public health priorities. In the coming year, MNDR will strengthen partnerships with healthcare networks, corporate health programs, and public agencies in order to embed our Health Operating System where it can deliver the most impact." Dr. Rachel Teoh, Co-CEO of MNDR, added, "Our strategy is not about scaling for its own sake, but scaling intelligently using data, automation, and empathy to deliver better outcomes at lower cost. In this future, AI doctors won't be confined to apps — intelligent robots and drones will roll and fly into the field during crises, delivering medicine to remote regions and maintaining care continuity when infrastructure fails. That's the future MNDR is building — a world where help always arrives." FY2025 Financial and Strategic Highlights Results for the year reflect short-term effects of MNDR's structural transformation, alongside ongoing execution of key international initiatives: Financial Discipline: Net loss narrowed to US$3.4 million from US$15.6 million in FY2024, driven by cost optimization and lower structural overhead. Revenue: FY2025 revenue was US$7.7 million, a 45.3% year-on-year decline, reflecting the strategic exit from legacy clinic operations towards a scalable virtual-care platform. Improved Operational Focus: The Company's streamlined operating structure reduced complexity and regulatory exposure associated with physical healthcare facilities, enabli…Read full document

Singapore, Singapore--(Newsfile Corp. - October 31, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced its financial results for the fiscal year ended June 30, 2025 ("FY2025"), and outlined its strategy to scale its proprietary AI-driven virtual-care platform across high-growth emerging markets. During FY2025, the Company completed its transition from an asset-heavy structure to an asset-light virtual-care platform, significantly reducing operational costs and positioning MNDR for sustainable, scalable growth. Management Commentary and Strategic Outlook – Efficiency for Public Good "FY2025 marked a defining year as MNDR completed its transformation into an AI-powered, asset-light health platform," said Dr. Siaw Tung Yeng, Co-CEO of MNDR. "In an era where healthcare systems face rising costs and stretched resources, our mission is to stay lean, stay intelligent, and stay aligned with public health priorities. In the coming year, MNDR will strengthen partnerships with healthcare networks, corporate health programs, and public agencies in order to embed our Health Operating System where it can deliver the most impact." Dr. Rachel Teoh, Co-CEO of MNDR, added, "Our strategy is not about scaling for its own sake, but scaling intelligently using data, automation, and empathy to deliver better outcomes at lower cost. In this future, AI doctors won't be confined to apps — intelligent robots and drones will roll and fly into the field during crises, delivering medicine to remote regions and maintaining care continuity when infrastructure fails. That's the future MNDR is building — a world where help always arrives." FY2025 Financial and Strategic Highlights Results for the year reflect short-term effects of MNDR's structural transformation, alongside ongoing execution of key international initiatives: Financial Discipline: Net loss narrowed to US$3.4 million from US$15.6 million in FY2024, driven by cost optimization and lower structural overhead. Revenue: FY2025 revenue was US$7.7 million, a 45.3% year-on-year decline, reflecting the strategic exit from legacy clinic operations towards a scalable virtual-care platform. Improved Operational Focus: The Company's streamlined operating structure reduced complexity and regulatory exposure associated with physical healthcare facilities, enabling management to concentrate resources on technology innovation and regional stability. Proprietary Large Language Model, Phi GPT: Phi GPT, launched by the Company in September 2025, forms the foundation of a new generation of clinical-support tools — including AI Checker and AI Notes — that employ retrieval augmented generation (RAG) and are fine-tuned on doctor-validated medical corpora. These tools use structured clinical data to deliver context-aware documentation and workflow automation, enhancing accuracy and efficiency across provider networks. Powered by Phi GPT, MNDR launched Aiko, a multilingual, context-aware health intelligence patient companion embedded in the Company's Health Operating System (HOS). Using structured patient data and validated clinical knowledge, Aiko delivers adaptive, privacy-secure recommendations that help patients manage medications, prevention, and chronic care. Ecosystem and Network Expansion: In Indonesia, MNDR expanded its doctor network through professional webinars and engagement programs that enhance clinical collaboration and digital readiness, reinforcing the Company's mission to build a connected community of care within its HOS. Extending its model beyond Asia, MNDR formed a strategic partnership with a Ghana-based healthcare provider to deliver virtual care and AI-powered health services to underserved communities in Africa—the Company's first entry into the region's fast-growing digital health market. MNDR maintains a disciplined capital strategy, utilizing its US$300 million At-the-Market (ATM) facility and US$10 million SEPA commitment to support growth initiatives and ensure balance sheet flexibility. About Mobile-health Network Solutions Mobile-health Network Solutions is a leading AI-powered digital health platform headquartered in Singapore, with operations across Southeast Asia and expanding into the US. The company provides telemedicine, AI-driven health tools, and virtual clinic infrastructure to empower patients and doctors worldwide. Its mission is to make healthcare accessible, intelligent, and human - through technology. For more information, please visit our website. Forward-Looking Statements Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to financial and business prospects, anticipated benefits of the Company's transition to an asset-light platform, the Company's goals and future activity, including continued development of proprietary technologies, strategic partnerships, and its capital initiatives. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law. For media inquiries, please contact: Mobile-health Network Solutions Investor Relations Contact: 2 Venture Drive, #07-06/07 Vision Exchange Singapore 608526 (+65) 6222 5223 Email: [email protected] Investor Relations Inquiries: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, New York 10036 Office: (646) 893-5835 Email: [email protected] To view the source version of this press release, please visit https://www.newsfilecorp.com/release/272739

Related articleQuarter not tagged2025-06-17

Mobile-health Network Solutions Announces H1 FY2025 Results; Continues on Drive Towards Scale and Profitability

Newsfile
Singapore, Singapore--(Newsfile Corp. - June 16, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced financial results for the first six months of its fiscal year 2025 ("H1 FY2025"). H1 FY2025 performance: Short-term impact from transition to leaner, stronger model For the period ended December 31, 2024, the company reported: Revenue of US$4.3 million, compared to US$6.6 million for the same prior period ("H1 FY2024") Net earnings of US$(1.7 million), compared to US$(1.5 million) in H1 FY2024 Cash and cash equivalents were at US$2.6 million, compared to US$6.7 million in H1 FY2024 The lower revenue was mainly due to a drop in the use of MNDR's telemedicine services from the year-ago period, following the closure of its CityGate clinic in Singapore. This was slightly offset by an increase in sales of medicine and medical devices during the period. The higher net loss resulted primarily from the decline in revenue. MNDR Co-CEO, Dr Siaw Tung Yeng, said: "The closure of our CityGate clinic was an inflection point as we transform from an asset-heavy model to a more asset-light business focused on delivering a globally scalable, AI-focused virtual care platform that can be deployed anywhere in the world." "We have since achieved many milestones, and are confident that our stronger, leaner core will not only enable us to reverse the short-term downtrend but set us on a more sustainable path to scale and create value for all our stakeholders. From the outset of our founding in 2016, our vision has been to deliver affordable, round-the-clock, quality care to patients via the transformative power of technology. With the rapid advancement of AI, we are well-placed to accelerate our journey towards that vision." Key operational milestones post H1 FY2025: Transformative acquisition of Lifepack and continued advancement in AI-led solutions MNDR made a transformative acquisition in April 2025 of Lifepack, a leading pharmacy and telehealth platform in Indonesia. Together, the Company can now offer advanced telehealth-pharmacy solutions for Indonesia's 280 million people as well, a majority of whom are underserved by telemedicine services. The Company also continued to make strides on delivering AI-driven healthcare innovation to healthcare providers a…Read full document

Singapore, Singapore--(Newsfile Corp. - June 16, 2025) - Mobile-health Network Solutions (Nasdaq: MNDR) ("MNDR" or "the Company"), a leading MedTech innovator ranked among Asia-Pacific's high-growth companies, today announced financial results for the first six months of its fiscal year 2025 ("H1 FY2025"). H1 FY2025 performance: Short-term impact from transition to leaner, stronger model For the period ended December 31, 2024, the company reported: Revenue of US$4.3 million, compared to US$6.6 million for the same prior period ("H1 FY2024") Net earnings of US$(1.7 million), compared to US$(1.5 million) in H1 FY2024 Cash and cash equivalents were at US$2.6 million, compared to US$6.7 million in H1 FY2024 The lower revenue was mainly due to a drop in the use of MNDR's telemedicine services from the year-ago period, following the closure of its CityGate clinic in Singapore. This was slightly offset by an increase in sales of medicine and medical devices during the period. The higher net loss resulted primarily from the decline in revenue. MNDR Co-CEO, Dr Siaw Tung Yeng, said: "The closure of our CityGate clinic was an inflection point as we transform from an asset-heavy model to a more asset-light business focused on delivering a globally scalable, AI-focused virtual care platform that can be deployed anywhere in the world." "We have since achieved many milestones, and are confident that our stronger, leaner core will not only enable us to reverse the short-term downtrend but set us on a more sustainable path to scale and create value for all our stakeholders. From the outset of our founding in 2016, our vision has been to deliver affordable, round-the-clock, quality care to patients via the transformative power of technology. With the rapid advancement of AI, we are well-placed to accelerate our journey towards that vision." Key operational milestones post H1 FY2025: Transformative acquisition of Lifepack and continued advancement in AI-led solutions MNDR made a transformative acquisition in April 2025 of Lifepack, a leading pharmacy and telehealth platform in Indonesia. Together, the Company can now offer advanced telehealth-pharmacy solutions for Indonesia's 280 million people as well, a majority of whom are underserved by telemedicine services. The Company also continued to make strides on delivering AI-driven healthcare innovation to healthcare providers and patients post-H1 FY2025: In January 2025, it secured $10 million in funding to further its AI-driven healthcare solutions, including its AI Agent - a platform designed to reduce healthcare providers' administrative load and improve their workflow for greater efficiency. In March 2025, MNDR launched AI Notes, a proprietary medical scribe that eliminates manual note-taking for doctors by capturing and contextualizing doctor-patient conversations and automatically generating structured clinical notes in real-time. In May 2025, it announced a tele-dentistry service that will soon let patients perform AI-enhanced dental scans at home using the MaNaDr telemedicine platform and receive expert-reviewed oral health reports within 24 hours. It has also calibrated its pricing structure and further integrated AI agents into its MaNaDr app to lower operational costs while continuing to deliver improved care and service. "Each of these developments will generate higher revenue for us and elevate MNDR to the forefront of AI-driven healthcare innovation, where efficiency, accessibility, and quality converge," Dr Siaw added. "With these latest initiatives already yielding positive results, we are confident that we will not only recover but surpass previous revenue levels, and that we can achieve breakeven by H2 FY2025 and achieve profitability before H1 FY2027." About Mobile-health Network Solutions Ranked #41 in the Financial Times 2024 listing of 500 High-growth Asia-Pacific Companies, we are the first telehealth provider from the Asia-Pacific region to be listed in the US. Through our platform, we offer personalized and reliable medical attention to users worldwide. Our platform allows our community of healthcare providers to have broader reach to users through virtual clinics without any start-up costs and the ability to connect to a global network of peer-to-peer support groups and partners. Our range of seamless and hassle-free telehealth solutions includes teleconsultation services, prescription fulfillment and other personalized services such as weight management programs and gender-specific care. For more information, please visit our website. FORWARD-LOOKING STATEMENTS Certain statements contained in this press release about future expectations, plans and prospects, as well as any other statements regarding matters that are not historical facts, may constitute "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements relating to the expected trading commencement and closing dates. The words "anticipate," "believe," "continue," "could," "estimate," "expect," "intend," "may," "plan," "potential," "predict," "project," "should," "target," "will," "would" and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. Forward-looking statements are not guarantees of future performance and involve risks and uncertainties that may cause the actual results to differ materially from the Company's expectations discussed in the forward-looking statements. These statements are subject to uncertainties and risks including, but not limited to, the following: the Company's ability to execute our strategies, manage growth and maintain our corporate culture; the Company's future business development, financial conditions and results of operations; expectations regarding demand for and market acceptance of our products and services; changes in technology; economic conditions; the growth of the telehealth solutions industry in Singapore and the other international markets the Company plans to serve; reputation and brand; the impact of competition and pricing; government regulations; fluctuations in general economic and business conditions in Singapore and the international markets the Company plans to serve and assumptions underlying or related to any of the foregoing and other risks contained in reports filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Any forward-looking statements contained in this press release speak only as of the date hereof, and Mobile-health Network Solutions specifically disclaims any obligation to update any forward-looking statement, whether because of new information, future events or otherwise, except as required by law. For media inquiries, please contact: Mobile-health Network Solutions Investor Relations Contact: 2 Venture Drive, #07-06/07 Vision Exchange Singapore 608526 (+65) 6222 5223 Email: [email protected] Investor Relations Inquiries: Skyline Corporate Communications Group, LLC Scott Powell, President 1177 Avenue of the Americas, 5th Floor New York, New York 10036 Office: (646) 893-5835 Email: [email protected] To view the source version of this press release, please visit https://www.newsfilecorp.com/release/255690

As of 2026-10-31 • Updated weeklySource: Earnings sourceIngestion runbook